HOME >> MEDICINE >> NEWS
Generic anti-inflammatory causes significantly fewer GI complications than branded medications

s with Celebrex or Vioxx.

As a result, the Pharmacy Benefits Management Strategic Healthcare Group for the Veterans Health Care Administration has recommended that all patients in their system currently on Vioxx be considered for conversion to etodolac.

"Once several other large health-care plans become aware of the safety data with etodolac and its cost-saving potential, many others may soon follow the lead of the VA," said Dr. Cryer, associate dean for minority affairs at UT Southwestern.

Other contributors to the Gastroenterology study were Dr. Salahuddin Kazi, associate professor of internal medicine, and Dr. George Sarosi Jr., assistant professor of GI/endocrine surgery, at UT Southwestern; and Dr. Rick Weideman, Dr. Kevin Kelly, Dr. Anh Cung, Dr. Kevin Roberts, Dr. Herbert Smith and Dr. Bertis Little of the Dallas Veterans Affairs Medical Center. Research was supported by the Dallas VA.


'"/>

Contact: Scott Maier
scott.maier@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
11-Nov-2004


Page: 1 2

Related medicine news :

1. Generic drug use varies widely by state, study reveals
2. Generics slow rising cost of prescription drugs in 2003
3. First quarter prescription drug spending: Generic drugs slow upward trend
4. Generic vs. name brand medications
5. COX-2 inhibitor could be safest anti-inflammatory drug for older people
6. Experts to discuss the affects of non-steroidal anti-inflammatory drugs (NSAIDs)
7. Existing anti-inflammatory drug could help children suffering from an inherited bone disease
8. New anti-inflammatory drug clears Alzheimers provoking protein from brains of mice
9. Insulin sensitizer has anti-inflammatory effect in diabetics
10. Aspirin steps up as anti-inflammatory for arteries
11. New estimates for the causes of child deaths worldwide

Post Your Comments:
(Date:6/19/2013)... CO (PRWEB) June 19, 2013 ... marketing company for coaches, announced today its affiliation ... means CoachingWebsites will offer exclusive websites and marketing ... partnerships. , “This new partnership with Active Intelligence ... their business to its fullest,” says Greer Van ...
(Date:6/19/2013)... 2013 The Mesothelioma Victims Center ... of the 2500 to 3000 citizens, who will be ... this year, about one third will be US Navy ... with this asbestos exposure form of cancer, or their ... to the nations most skilled mesothelioma compensation settlement attorneys, ...
(Date:6/19/2013)... Middle market merger and acquisition (M&A) activity ... cash rich buyers seek to place their capital in ... transactions have a good deal in common. The acquirer ... and quality of the target company’s earnings. Potential risks ... diligence involves a middle market company, whose value consists ...
(Date:6/18/2013)... 19, 2013 oBand Surgery Centers, a ... holding complimentary weight loss seminars in Los Angeles this ... be accessed at their official website. oBand Surgery Centers ... time. Their highly skilled panel of surgeons and dedicated ... , A senior executive working with oBand Surgery Centers ...
(Date:6/18/2013)... Philadelphia, PA, June 19, 2013 Recent studies ... coverage of bullying-related suicide among young people, led ... to assemble an expert panel to focus on ... about the complex relationship between youth involvement in ... Bullying among youth is a significant public health ...
Breaking Medicine News(10 mins):Health News:CoachingWebsites (Websites for Coaches) Announces Their Partnership With Active Intelligence, LLC 2Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For Instant Access To The Nation's Top Asbestos Lawyers-Better Compensation 2Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For Instant Access To The Nation's Top Asbestos Lawyers-Better Compensation 3Health News:Newport Board Group, a National Business Advisory Firm of CEOs Cautions Buyers on 5 Questions to Ask Before Acquiring a Technology-Based Middle Market Company 2Health News:Newport Board Group, a National Business Advisory Firm of CEOs Cautions Buyers on 5 Questions to Ask Before Acquiring a Technology-Based Middle Market Company 3Health News:oBand Surgery Centers Will Hold Complimentary Weight Loss Seminars in Los Angeles in June 2Health News:Bullying and suicide among youth is a public health problem 2
(Date:6/18/2013)... -- New-generation electronic designs are focused on rugged ... circuitry is increasing the number of functions it ... performs at. Connecting cables from the active elements ... as cameras or detectors, must be small, flexible ... custom cable designs for high-quality signal and EMI ...
(Date:6/18/2013)... And EMERYVILLE, Calif. , June ... final results today from a Phase 2/3 clinical ... demonstrating a statistically significant improvement in levodopa-induced dyskinesia ... week 8 versus placebo in the Unified Dyskinesia ... formulation of amantadine intended for once-nightly administration that ...
(Date:6/18/2013)... 18, 2013   Polymer Technology Systems, Inc. ... Health Group to integrate the CardioChek ® ... administered by health systems across the country. The ... and distributed through Hanson Medical Systems , ... cholesterol, LDL cholesterol, triglycerides, and glucose. ...
Breaking Medicine Technology:Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 2Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 3Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 4Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 5Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 6Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 2Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 3
Cached News: